-+ 0.00%
-+ 0.00%
-+ 0.00%

Spyre Therapeutics closes follow-on offering, raises USD 463.5 million

PUBT·04/16/2026 20:16:47
Listen to the news
Spyre Therapeutics closes follow-on offering, raises USD 463.5 million
  • Spyre Therapeutics closed an underwritten follow-on offering of 7,475,000 common shares at USD 62 per share.
  • Gross proceeds totaled about USD 463.5 million before underwriting discounts, commissions, and offering expenses.
  • Underwriters exercised option in full to buy 975,000 additional shares.
  • Jefferies, Goldman Sachs, Evercore ISI, and Guggenheim Securities served as joint book-running managers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604161615PRIMZONEFULLFEED9691666) on April 16, 2026, and is solely responsible for the information contained therein.